Primary Care Enhanced Services
Overview
Summary, notice description and lot information
In a recent procurement process overseen by the NHS Lincolnshire Integrated Care Board, an intention to award notice was made public for the provision of Primary Care Enhanced Services, covering various facets such as Phlebotomy, Warfarin, and Safeguarding. This procurement is under the Provider Selection Regime, specifically the Health Care Services Regulations 2023, excluding the Public Contracts Regulations 2015 and Procurement Act 2023. The associated procurement stage is at the 'Award' phase, and the notice marks the beginning of a standstill period, allowing providers to make representations by 12th September 2025.
This contract, valued at £79,034 and facilitated through a limited procurement method, is anticipated to run from 1st April 2025 to 31st March 2026, serving the UKF3 region. This tender presents substantial opportunities for businesses, particularly those within the healthcare services sector, to collaborate with the NHS and reinforce service delivery in the region. With the procurement focusing on maintaining high standards of quality and innovation, as well as social value and service sustainability, companies proficient in these areas are well-suited to engage with the contract.
The existing and potential suppliers, such as small and medium enterprises (SMEs), could leverage this procurement to expand their service offerings in general-practitioner services. The engagement in primary care services could further enhance a supplier’s reputation and contribute to tackling health inequalities within the community.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing. The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS79,034. The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- RESIDENTIAL CARE PLACEMENT (LD/ASD) - 1421b (TG) in Rushcliffe
- RESIDENTIAL CARE PLACEMENT (Mental Health/ASD) - 1425 (CH) in Rushcliffe
- RESIDENTIAL CARE PLACEMENT (Mental Health/ASD) - 1425 (CH) in Rushcliffe
- RESIDENTIAL CARE PLACEMENT (LD/PD) - 1419 (LH) in Rushcliffe
- RESIDENTIAL CARE PLACEMENT (MH) - 1402b (AH) in Rushcliffe
- NGH - Living Heart Community in West Northamptonshire